Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metyridine SCHEMBL30481621 | 1.00 | HRH1 (0.55) | HRH1HRH3CA12CA1CA2 | |
| SCHEMBL29436004 | 0.89 | CA12 (0.49) | HRH1HRH3CA12CA1CA2 | |
| SCHEMBL6859512 | 0.88 | HRH1 (0.55) | HRH1HRH3CA12CA1CA2 | |
| Metyridine SCHEMBL8450058 | 0.87 | CA12 (0.44) | HRH1HRH3CA12CA1CA2 | |
| SCHEMBL8243986 | 0.86 | HRH1 (0.58) | HRH1HRH3CA12CA1CA2 | |
| SCHEMBL7449287 | 0.83 | HRH1 (0.59) | HRH1HRH3CA12CA1CA2 | |
| SCHEMBL13451317 | 0.82 | CYP1A2 (0.59) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL13451318 | 0.81 | KDM4E (0.56) | HRH3ALDH1A1CYP1A2CYP2C19TDP1 | |
| SCHEMBL27952913 | 0.81 | CA12 (0.45) | HRH1HRH3CA12CA1CA2 | |
| SCHEMBL18704138 | 0.81 | HRH1 (0.51) | HRH1HRH3CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 652 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025229128-A1 | ANTI-INFLAMMATORY POLYPEPTIDES DERIVED FROM HELMINTHIC GLUTAMATE DEHYDROGENASE (HEGDH), METHODS AND USES THEREOF | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2025-11-06 | — | — | WO | claimed |
| CN-119838022-A | Amatoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-118557747-A | Conjugates of cell binding molecules and camptothecin analogs | 杭州多禧生物科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118434765-A | BCMA monoclonal antibodies and antibody-drug conjugates | 杭州多禧生物科技有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-118215676-A | Specific conjugation of antibody drug conjugates | 杭州多禧生物科技有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117384085-A | Method for preparing 2-vinyl pyridine by catalytic pyrolysis | 江苏亚泰化工有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-116854626-A | Preparation method of 2-vinyl pyridine | 河南省科学院高新技术研究中心 | 2023-10-10 | — | — | CN | claimed |
| CN-116143678-A | Conjugate linker, cell-binding molecule-drug conjugate containing the same, and preparation and application thereof | 杭州多禧生物科技有限公司 | 2023-05-23 | — | — | CN | claimed |
| US-20170135347-A1 | INSECTICIDAL, MITICIDAL, NEMATICIDAL, MOLLUSCICIDAL, MICROBICIDAL, OR BACTERICIDAL COMPOSITION AND METHOD FOR CONTROLLING PEST | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-05-18 | — | — | US | claimed |
| CN-106659160-A | Insecticide, miticide, nematicide, molluscicide, disinfectant, or bactericide composition, and pest control method | 日产化学工业株式会社 | 2017-05-10 | — | — | CN | claimed |
| US-7247645-B2 | Dihydropyridine derivatives | AJINOMOTO CO., INC. (JP) | 2007-07-24 | — | — | US | claimed |
| US-20040249099-A1 | Acrylic esters of 2-cyano-2, 4 pentenedioic acid | CHEMENCE, INC. | 2004-12-09 | — | — | US | claimed |
| US-20020147222-A1 | Dihydropyridine derivatives | AJINOMOTO CO. INC (JP) | 2002-10-10 | — | — | US | claimed |
| EP-1191021-A1 | DIHYDROPYRIDINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2002-03-27 | — | — | EP | claimed |
| US-20020025477-A1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-28 | — | — | US | claimed |
| EP-1172878-A2 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-01-16 | — | — | EP | claimed |
| WO-1992009651-A1 | POLYCYANOACRYLATE FOAM | CHEMENCE LIMITED (GB) | 1992-06-11 | — | — | WO | claimed |
| WO-1990009096-A2 | METHOD OF SCREENING AND CLASSIFYING COMPOUNDS | CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) | 1990-08-23 | — | — | WO | claimed |
| EP-0021758-B1 | VETERINARY PREPARATIONS FOR RUMINANT ANIMALS | BEECHAM GROUP PLC (GB) | 1984-04-04 | — | — | EP | claimed |
| US-4009266-A | METHOD OF TREATMENT OF NEMATODE PARASITE INFECTIONS IN DOMESTIC ANIMALS | AYALEW LIYEW | 1977-02-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170135347-A1 | INSECTICIDAL, MITICIDAL, NEMATICIDAL, MOLLUSCICIDAL, MICROBICIDAL, OR BACTERICIDAL COMPOSITION AND METHOD FOR CONTROLLING PEST | DDT, ACHE, DRD5 | HRH1 1368/4885HRH3 1903/4885CA12 4139/4885 |
| US-20020147222-A1 | Dihydropyridine derivatives | CACNA1B, CACNA1D, CACNA1C | HRH1 596/4885HRH3 1086/4885CA12 4539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.